Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bcworldpharm Co's share price for the quarter that ended in Jun. 2026 was ₩3180. Bcworldpharm Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 10 Mil. Therefore, Bcworldpharm Co's market cap for the quarter that ended in Jun. 2026 was ₩32,503 Mil.
Bcworldpharm Co's quarterly market cap
declined
from Dec. 2025 (₩56,334 Mil) to Mar. 2026 (₩46,454 Mil) and
declined
from Mar. 2026 (₩46,454 Mil) to Jun. 2026 (₩32,503 Mil).
Bcworldpharm Co's annual market cap
declined
from Dec. 2023 (₩54,515 Mil) to Dec. 2024 (₩39,406 Mil) but then
increased
from Dec. 2024 (₩39,406 Mil) to Dec. 2025 (₩56,334 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bcworldpharm Co's Enterprise Value for Today is ₩103,914 Mil.
Bcworldpharm Co (XKRX:200780) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bcworldpharm Co Market Cap Related Terms
Bcworldpharm Co Market Cap Historical Data
* Premium members only.
The historical data trend for Bcworldpharm Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:200780 vs LLY, JNJ, ABBV: Market Cap Comparison
For the Drug Manufacturers - General subindustry, Bcworldpharm Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bcworldpharm Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Bcworldpharm Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bcworldpharm Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bcworldpharm Co (XKRX:200780) has a Market Cap of ₩31,071 Mil as of Sep. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bcworldpharm Co and its competitors. According to the industry distribution chart, Bcworldpharm Co ranks #797 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 77.8%.
Is Bcworldpharm Co's Market Cap too high?
Bcworldpharm Co's current Market Cap is ₩31,071 Mil. Based on the distribution chart, Bcworldpharm Co ranks #797 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Bcworldpharm Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bcworldpharm Co's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Bcworldpharm Co ranks #797 out of 1024 companies for Market Cap. This places Bcworldpharm Co in the lower half of its industry. The industry median Market Cap is 231.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 231.19, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bcworldpharm Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 231.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bcworldpharm Co's current Market Cap is ₩31,071 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bcworldpharm Co stock overvalued right now?
Based on GuruFocus' analysis, Bcworldpharm Co (XKRX:200780) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,477.85, compared to a current price of ₩3,040.00 — trading 44.5% below its estimated fair value. The current Market Cap is ₩31,071 Mil. Bcworldpharm Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bcworldpharm Co (XKRX:200780), the current Market Cap is ₩31,071 Mil as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bcworldpharm Co (XKRX:200780) Overvalued in 2026?
Based on GuruFocus' analysis, Bcworldpharm Co stock appears to be undervalued.
The current stock price of ₩3,040.00 is trading 44.5% below its estimated GF Value™ of ₩5,477.85.
GuruFocus considers Bcworldpharm Co to be Possible Value Trap.
Key valuation signals for XKRX:200780:
Market Cap: ₩31,071 Mil
GF Value™: ₩5,477.85 vs. price of ₩3,040.00 (44.5% below fair value)
No single metric tells the full story. See the XKRX:200780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bcworldpharm Co Ltd is a pharmaceutical company. The company is engaged in research and develop new and improved drugs through R&D and technological innovation. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics.
66GF Score
Get the complete analysis for XKRX:200780
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:200780 has been successfully added to your 
